Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of pregnane derivative in preparation of osteoclast differentiation inhibitor

A technology of osteoclast and differentiation inhibition, applied in the field of biomedicine, can solve the problems of venous thrombosis, can not significantly reduce the risk of atypical fractures, and osteonecrosis of the jaw

Active Publication Date: 2020-09-22
GUANGDONG INST OF MICROBIOLOGY GUANGDONG DETECTION CENT OF MICROBIOLOGY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these drugs can improve the bone mineral density of patients with osteoporosis to a certain extent, they cannot significantly reduce the risk of atypical fractures, and there are various side effects at the same time, such as bisphosphonates can cause osteonecrosis of the jaw, raloxix Fen can cause venous thrombosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pregnane derivative in preparation of osteoclast differentiation inhibitor
  • Application of pregnane derivative in preparation of osteoclast differentiation inhibitor
  • Application of pregnane derivative in preparation of osteoclast differentiation inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1: Osteoclast Differentiation Inhibitory Activity Test

[0018]

[0019] 1. Experimental method

[0020] Cell culture: take 8-week-old C57BL / 6 mouse femoral marrow cells, and use MEM-α complete medium containing 10ng / mL M-CSF (containing 10% fetal bovine serum (FBS), 100U / mL penicillin and 100μg / mL streptomycin), cultured in a carbon dioxide incubator at 37°C for 24 hours, discarded the culture medium, washed the cells with phosphate buffered saline (PBS) slowly for 1 or 2 times, removed the suspended cells, and then washed them with 4mL MEM - α complete medium Gently blow off the adherent cells and centrifuge at 1000RPM / min for 10min to obtain mouse bone marrow macrophages (BMMs).

[0021] Induce osteoclast formation: BMMs cells were diluted to a density of 1×10 with MEM-α complete medium containing 10 ng / mL LM-CSF cytokine 5 cells / mL of cell suspension, and seeded in 96-well plate, 100 μL per well. After culturing for 24 hours to adhere to the wall, the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a pregnane derivative in preparation of an osteoclast differentiation inhibitor. According to the application of the pregnane derivative in preparation of the osteoclast differentiation inhibitor, the structural formula of the pregnane derivative is shown as a formula 1. It is found through tests that the pregnane derivative has a direct and remarkable inhibiting effect on osteoclast differentiation, and therefore the pregnane derivative can serve as an osteoclast differentiation inhibitor medicine to be used for treating various diseases such as osteoporosis caused by osteoclast differentiation.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to the application of pregnane derivatives in the preparation of osteoclast differentiation inhibitors. Background technique [0002] Osteoporosis is a systemic bone metabolic disease. With the prolongation of human life span and the acceleration of population aging, the incidence of osteoporosis is increasing year by year. It has become one of the important chronic diseases that affect people's quality of life. public health issues. According to statistics at the 2014 American Society for Bone and Mineral Research (ASBMR) annual meeting, osteoporotic fractures are one of the most important chronic diseases in the 21st century, and 1 / 2 of the elderly women and 1 / 3 of the elderly men in the world will suffer from osteoporosis. Loose fractures. Therefore, the development of effective anti-osteoporosis drugs is of great significance for improving the quality of life of humans, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/57A61P19/10
CPCA61K31/57A61P19/10
Inventor 刘志红黄丹娥徐峻谢黎炜顾琼郑双佳许国焕韩木兰
Owner GUANGDONG INST OF MICROBIOLOGY GUANGDONG DETECTION CENT OF MICROBIOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products